Critical Factors Affecting Pharmaceutical R&D and the Availability of New Drugs

Dr Jorge Mestre-Ferrandiz, OHE's Director of Consulting, was a recent guest lecturer at Imperial College London. His comprehensive presentation covered the gamut of issues that influence the rate and direction of R&D for medicines, including regulatory approval requirements, the patent system, the economics of R&D, the roles of the public and private sectors, “push” and “pull” incentives, and the influence of capital markets.

For additional information, please contact Dr. Jorge Mestre-Ferrandiz

 

Posted in Drug Development/R&D, Health Technology Assessment, Innovation, Pricing and Reimbursement, Risk-sharing Arrangements | Tagged Presentations